The potential of CYP46A1 as a novel therapeutic target for neurological disorders: An updated review of mechanisms
Mohaddeseh Sadat Alavi, Gholamreza Karimi, Hussein A. Ghanimi, Ali Roohbakhsh
Topics & Concepts
CholesterolNeuroscienceAmyotrophic lateral sclerosisNeuroprotectionBiologyPharmacologyMedicineDiseaseInternal medicineEndocrinologyCholesterol and Lipid MetabolismNuclear Receptors and SignalingPeroxisome Proliferator-Activated Receptors